Menu UF Health Home Menu
 

News Category Subscribe to RSS Feed

MarkAtkinson760x300

Study of GABA in Healthy Volunteers: Pharmacokinetics and Pharmacodynamics

Published: Dec 6th, 2015

UFDI Director Mark Atkinson, Ph.D. and collaborators found that GABA is rapidly absorbed and tolerated in human beings. They believe that its endocrine effects suggest potential therapeutic benefits for diabetes.

LogoText

Targeted Deep Sequencing in Multiple-Affected Sibships of European Ancestry Identifies Rare Deleterious Variants in PTPN22 that Confer Risk for Type 1 Diabetes

Published: Dec 6th, 2015

UF investigators and collaborators found that rare deleterious variants in PTPN22 exist and can affect T1D risk.

Schatz 2015 Medium

Vitamin D status in youth with type 1 and type 2 diabetes enrolled in the Pediatric Diabetes Consortium is not worse than in youth without diabetes

Published: Dec 4th, 2015

UFDI Investigator Desmond Schatz, M.D. and other researchers found that vitamin D insufficiency is present in a substantial proportion of youth with diabetes, particularly minorities, but the prevalence appears similar […]

Haller-Michael_2907_Kiewel

Effect of Metformin Added to Insulin on Glycemic Control Among Overweight/Obese Adolescents With Type 1 Diabetes: A Randomized Clinical Trial

Published: Dec 2nd, 2015

UFDI Investigator Michael Haller, M.D. and other researchers found that among overweight adolescents with type 1 diabetes, the addition of metformin to insulin did not improve glycemic control after 6 […]

nPODThumb

Insulitis and β-Cell Mass in the Natural History of Type 1 Diabetes

Published: Nov 21st, 2015

UFDI and nPOD investigators found that the presence of β-cells as well as insulitis several years after T1D diagnosis in children and young adults suggest that the chronicity of islet […]

shutterstock_92474629-450x305

Immune Depletion in Combination with Allogeneic Islets Permanently Restores Tolerance to Self-Antigens in Diabetic NOD Mice

Published: Nov 20th, 2015

UFDI researchers Amanda Posgai, Ph.D. and Mark Atkinson, Ph.D. and collaborators examine a new approach for preserving beta cell function in patients with recent onset T1D.

NIHLogo

New funding opportunities available

Published: Nov 19th, 2015

From the National Institutes of Health’s National Institute of Aging: Diabetes and Cardiovascular Disease in Older Adults (R01) “This Funding Opportunity Announcement invites applications that propose basic, clinical, and epidemiological […]

MarkAtkinson760x300

Study of GABA in Healthy Volunteers: Pharmacokinetics and Pharmacodynamics

Published: Nov 12th, 2015

UFDI Researcher Mark Atkinson, Ph.D. and collaborators found that that GABA is rapidly absorbed and tolerated in human beings, and its endocrine effects suggest potential therapeutic benefits for diabetes.

Diabetes5k

Heroes Dash for Diabetes 5k

Published: Nov 9th, 2015

The Dash for Diabetes 5k will be a hero themed 5k race in which participants have the option of dressing up as their superhero of choice and running the race […]

Beyond

Beyond the brain: disrupted in schizophrenia 1 regulates pancreatic β-cell function via glycogen synthase kinase-3β

Published: Nov 9th, 2015

Individuals with schizophrenia and their first-degree relatives have higher rates of type 2 diabetes than the general population (18-30 vs. 1.2-6.3%), independent of body mass index and antipsychotic medication, suggesting […]